WideTrial Supports NIH-Funded Expanded Access Program for Investigational ALS Drug

Program to provide investigational drug to ALS patients who would otherwise be ineligible for clinical trials SANTA CLARA, Calif., Nov. 20, 2024 /PRNewswire/ — WideTrial, an innovator of expanded access program (EAP) solutions, announced its participation in an NIH-funded collaboration…